22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- World Industrial Design Association launched in Shanghai
- Green belt helps curb desertification, invigorate local industries in Xinjiang
- Tiny fossil egg sets new world record
- A life on the front line of drug war
- Rural elderly care system to be revamped
- Omega-3 pork launched to fortify nation's nutrition
